HCC
CLDX icon

Hirtle Callaghan & Co’s Celldex Therapeutics CLDX Stock Holding History

Hirtle Callaghan & Co’s Portfolio CLDX Stock Details CLDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-233
Closed -$64K – 78
2014
Q4 		$64K Buy
+233
New +$64K 0.01% 269